From professional translators, enterprises, web pages and freely available translation repositories.
myocyte
lihassolut
Last Update: 2014-12-09
Usage Frequency: 6
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
cardiac myocyte
sydänlihassolut
Last Update: 2014-12-09
Usage Frequency: 6
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
myocyte, cardiac
sydänlihassolut
Last Update: 2014-12-09
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
cardiac myocyte, nos
sydänlihassolut
Last Update: 2014-12-09
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
cardiac myocyte (cell)
sydänlihassolut
Last Update: 2014-12-09
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
smooth muscle myocyte
sileälihassolut
Last Update: 2014-12-09
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
myocyte, smooth muscle
sileälihassolut
Last Update: 2014-12-09
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
myocyte of smooth muscle
sileälihassolut
Last Update: 2014-12-09
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
consistent with the clinical effects of replagal, treatment with the enzyme reduced accumulation of gb3 in many cell types, including renal glomerular and tubular epithelial cells, renal capillary endothelial cells (cardiac and dermal capillary endothelial cells were not examined) and cardiac myocytes.
replagalin kliinisten vaikutusten mukaisesti entsyymihoito vähensi gb3: n akkumulaatiota monissa solutyypeissä, munuaisten glomerulaariset ja tubulaariset epiteelisolut, munuaisten kapillaariset endoteelisolut (sydämen ja ihon kapillaarisia endoteelisoluja ei tutkittu) ja sydänlihassolut mukaan lukien.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
